Literature DB >> 8054364

Fibril formation from recombinant human serum amyloid A.

T Yamada1, B Kluve-Beckerman, J J Liepnieks, M D Benson.   

Abstract

Three isotypes of human serum amyloid A (SAA), SAA1, SAA2 beta, and SAA4 were expressed at high levels in Escherichia coli (E. coli) using a pET vector expression system. Each SAA cDNA was ligated to the vector pET-21a(+) and transformed into E. coli, strain BL21(DE3)pLysS. Expression conditions required high concentrations of antibiotics in order to obtain a high ratio of synthesized SAA to total E. coli proteins. Each recombinant SAA (rSAA) was purified by molecular sieve chromatography followed by chromatofocusing or hydrophobic interaction chromatography. The yield of purified protein was 5-10 mg per 11 of culture. When subjected to in vitro fibril forming conditions, rSAA1 formed amyloid-like fibrils confirmed by Congo red staining and electron microscopy. In contrast, rSAA2 beta and rSAA4 showed negative Congo red staining and curvilinear or flattened fibrillar structures on electron microscopy. This suggests that SAA1 has greater potential for forming amyloid fibrils than either SAA2 beta or SAA4.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8054364     DOI: 10.1016/0925-4439(94)90044-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  A putative role for cathepsin K in degradation of AA and AL amyloidosis.

Authors:  C Röcken; B Stix; D Brömme; S Ansorge; A Roessner; F Bühling
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Inflammation protein SAA2.2 spontaneously forms marginally stable amyloid fibrils at physiological temperature.

Authors:  Zhuqiu Ye; Diane Bayron Poueymiroy; J Javier Aguilera; Saipraveen Srinivasan; Yun Wang; Louise C Serpell; Wilfredo Colón
Journal:  Biochemistry       Date:  2011-10-05       Impact factor: 3.162

3.  Automated measurement of a constitutive isotype of serum amyloid A/SAA4 and comparison with other apolipoproteins.

Authors:  T Yamada; A Wada; T Yamaguchi; Y Itoh; T Kawai
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

4.  Urea-induced denaturation of apolipoprotein serum amyloid A reveals marginal stability of hexamer.

Authors:  Limin Wang; Wilfredo Colón
Journal:  Protein Sci       Date:  2005-06-03       Impact factor: 6.725

5.  Differential plasma clearance of murine acute-phase serum amyloid A proteins SAA1 and SAA2.

Authors:  B Kluve-Beckerman; T Yamada; J Hardwick; J J Liepnieks; M D Benson
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

6.  Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel.

Authors:  Limin Wang; Hilal A Lashuel; Thomas Walz; Wilfredo Colon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

7.  Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis.

Authors:  Shobini Jayaraman; Donald L Gantz; Christian Haupt; Olga Gursky
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-25       Impact factor: 11.205

8.  Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer.

Authors:  Yun Wang; Saipraveen Srinivasan; Zhuqiu Ye; J Javier Aguilera; Maria M Lopez; Wilfredo Colón
Journal:  Biochem Biophys Res Commun       Date:  2011-03-31       Impact factor: 3.575

9.  Adenoviral expression of murine serum amyloid A proteins to study amyloid fibrillogenesis.

Authors:  M S Kindy; A R King; J Yu; C Gerardot; J Whitley; F C de Beer
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

10.  Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis.

Authors:  H Patel; J Bramall; H Waters; M C De Beer; P Woo
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.